AzTrials
AzTrials

Osteoarthritis, KneeNCT06181955

Extracorporeal Shock Wave Therapy in Osteoarthritis

A study testing Extracorporeal Shock Wave Therapy and conventional physical therapy in people with Osteoarthritis, Knee, run by King Saud University at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study has examined the effectiveness of extracorporeal shock wave therapy along with conventional physical therapy on functional ability in grade IV knee osteoarthritis. Intervention program was performed for four weeks. Read more about this study

Who is it for?
Ages 45 to 60 years
Conditions the study is for
Osteoarthritis, Knee
What is being tested?
Extracorporeal Shock Wave Therapy and conventional physical therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSaudi Arabia
Study dates
6 Dec 2021to 27 Apr 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Grade IV primary knee Osteoarthritis (OA) diagnosed by an orthopaedic surgeon based on the Kellgren-Lawrence score

Who cannot join

  • Secondary knee OA,
  • rheumatoid arthritis,
  • psoriatic arthritis,
  • the presence of any red flags (metastatic growth, thrombophlebitis),
  • neurologic or psychiatric impairments,
  • tissue injuries of the knee joint,
Show all 10Show fewer
  • previous knee joint replacement or other surgeries in the knee joint,
  • already received ESWT,
  • Intra articular injection
  • unable to walk independently

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • King Saud University

    Riyadh, 11433

Other trials in Saudi Arabia

About this study

Official title: Effectiveness of Extracorporeal Shock Wave Therapy on Improving Functional Ability in Knee Osteoarthritis (Grade iv)

The present study has examined the effectiveness of extracorporeal shock wave therapy along with conventional physical therapy on functional ability in grade IV knee osteoarthritis. Intervention program was performed for four weeks. Conventional physical therapy included ultrasound therapy, isometric quadriceps, straight leg raising (SLR) and isometric hip adductor strengthening exercises. Functional ability was assessed using the Lower Extremity Functional Scale (LEFS) score.

Being tested
Extracorporeal Shock Wave Therapy, conventional physical therapy
Keywords
Physical therapy, Lower Extremity Functional Scale score, Ultrasound therapy, Exercises, Quadriceps
Medical subject headings
Osteoarthritis, Knee, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extracorporeal Shock Wave TherapyOther

    The ESWT was performed by an ESWT instrument (Chattanooga) once a week for four consecutive weeks (a total of four sessions).

  • conventional physical therapyOther

    Conventional physical therapy consisted of ultrasound therapy and three types of knee-strengthening exercises.

Study groups in NCT06181955
Study groupRoleWhat they receive
ExperimentalExperimentalThe participants in this group received Extracorporeal Shock Wave Therapy (ESWT) in addition to conventional physical therapy.
Receives: Other: Extracorporeal Shock Wave Therapy; Other: conventional physical therapy
Control groupActive comparatorThe participants in this group received conventional physical therapy only.
Receives: Other: conventional physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lower Extremity Functional Scale (LEFS) score

    It is a measurement tool used to assess the functional status and ability of individuals with lower extremity musculoskeletal conditions or injuries. The LEFS consists of 20 items and each item is rated on a scale from 0 to 4, with 0 indicating extreme difficulty to perform the activity and 4 indicating no difficulty at all. The scores for all items are summed to obtain a total score ranging from 0 to 80.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2023
  2. Study start6 Dec 2021
  3. Primary completion2 Feb 2022
  4. Study completion27 Apr 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two group experimental-control design
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06181955
Sponsor's protocol ID
AWH/EC/03/2021/2
Status last verified
Dec 2023
First submitted
13 Dec 2023
Last updated
26 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Extracorporeal Shock Wave Therapy and conventional physical therapy in people with Osteoarthritis, Knee, run by King Saud University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lower Extremity Functional Scale (LEFS) score (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in